PARP Inhibitor Regimen in Ovarian Cancer (IPIROC)

ICMR Funds Pan-India Clinical Trial to Test Cost-Effective Dosing of PARP Inhibitor in Ovarian Cancer

The Indian Council of Medical Research (ICMR) has funded a new pan-India clinical trial to evaluate a cost-effective dosing strategy…